Literature DB >> 30566259

Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Agnieszka M Mazurek1, Tomasz Rutkowski2, Mirosław Śnietura3, Wojciech Pigłowski3, Rafał Suwiński4, Krzysztof Składowski2.   

Abstract

BACKGROUND: Development of biomarker analysis using the circulating cell-free DNA (cfDNA) methodology is a challenge for noninvasive cancer diagnosis. In this study, a comparison between the plasma and tumor tissue HPV16 DNA viral loads (VLs) has been presented.
METHODS: Real-time polymerase chain reaction was performed for quantitating of HPV16 DNA in the plasma and tumor samples of patients with oropharyngeal cancer.
RESULTS: Among the tissues, HPV16-positive patients with oropharyngeal squamous cell carcinoma, nonsmoking patients, displayed significantly higher HPV16 DNA VLs in their tissue. No smoking and advanced N disease were the most important predictors for cHPV16 DNA (circulating HPV16 DNA) detection. The cHPV16-positive women displayed significantly higher VLs in their tumor tissues compared to the men, although without notable impact on the blood detection.
CONCLUSIONS: Many factors were responsible for human papillomavirus DNA circulation in blood. As a result of the small size of the analyzed group, some observed discrepancies need to be proven on a larger cohort.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  circulating HPV16 DNA; human papillomavirus; oropharyngeal cancer; plasma; viral load

Year:  2018        PMID: 30566259     DOI: 10.1002/hed.25368

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  Putative Role of Circulating Human Papillomavirus DNA in the Development of Primary Squamous Cell Carcinoma of the Middle Rectum: A Case Report.

Authors:  Maria Raffaella Ambrosio; Remo Vernillo; Sabrina De Carolis; Antonietta Carducci; Lucia Mundo; Alessandro Ginori; Bruno Jim Rocca; Valerio Nardone; Alessandra Lucenti Fei; Tommaso Carfagno; Stefano Lazzi; Monica Cricca; Piero Tosi
Journal:  Front Oncol       Date:  2019-02-21       Impact factor: 6.244

Review 2.  Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges.

Authors:  Mariana Chantre-Justino; Gilda Alves; Lucas Delmonico
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

3.  Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.

Authors:  Kiyoshi Misawa; Atsushi Imai; Hirotaka Matsui; Akinori Kanai; Yuki Misawa; Daiki Mochizuki; Masato Mima; Satoshi Yamada; Tomoya Kurokawa; Takuya Nakagawa; Hiroyuki Mineta
Journal:  Oncogene       Date:  2020-05-15       Impact factor: 9.867

4.  Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer.

Authors:  Tomasz W Rutkowski; Agnieszka M Mazurek; Mirosław Śnietura; Beata Hejduk; Maja Jędrzejewska; Barbara Bobek-Billewicz; Andrea d'Amico; Wojciech Pigłowski; Andrzej Wygoda; Krzysztof Składowski; Zofia Kołosza; Piotr Widłak
Journal:  J Transl Med       Date:  2020-04-15       Impact factor: 5.531

5.  Significance of HPV16 Viral Load Testing in Anal Cancer.

Authors:  Ewa Małusecka; Ewa Chmielik; Rafał Suwiński; Monika Giglok; Dariusz Lange; Tomasz Rutkowski; Agnieszka M Mazurek
Journal:  Pathol Oncol Res       Date:  2020-04-07       Impact factor: 3.201

6.  Diagnostic Accuracy of HPV Detection in Patients with Oropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-Analysis.

Authors:  Kathrine Kronberg Jakobsen; Amanda-Louise Fenger Carlander; Simone Kloch Bendtsen; Martin Garset-Zamani; Charlotte Duch Lynggaard; Christian Grønhøj; Christian von Buchwald
Journal:  Viruses       Date:  2021-08-26       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.